Drostanolone

DB00858ExperimentalIllicitSmall molecule

Drostanolone (also known as dromostanolone) is a potent synthetic androgenic anabolic steroid similar to testosterone. Drostanolone is indicated in postmenopausal women with recurrent breast cancer, in a combined hormone therapy.

Mechanism: Pharmacologically active on Androgen receptor
Curator reviewed
Formula / weight: C₂₀H₃₂O₂ · 304.4669 g/mol (avg)
Also known as: Dromostanolone · Medrosteron · Medrotestron · Metholone

Resolves to

Compound

UNII7DR7H00HDTCAS58-19-5ChEMBLCHEMBL1582ChEBI34838PubChem6011KEGGC14605

Clinical / RWD

RxNorm23678PharmGKBPA164760855

Structure

InChIKeyIKXILDNPCZPPRV-RFMGOVQKSA-NSMILES[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)[C@H](C)C[C@]12C

Targets

P10275AR

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Drostanolone, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account